A newly published study points to a possible association between GLP-1 medications and hair loss in men, The Washington Post reports. The finding adds to a growing set of reports about unexpected side effects tied to the popular weight-loss and diabetes drugs.
The Washington Post's report is one of several recent items drawing attention to physical changes reported by people using these medications. Gizmodo reported that hair loss was only part of the picture, noting that some Ozempic users have also described problems with their nails.
That nail issue was examined in a controlled study, according to Medical Xpress, which reported that nail detachment was more than four times as common among GLP-1 users. Medical Xpress described it as the first controlled study of its kind on the subject.
BBC Science Focus Magazine also covered the topic, reporting that experts have identified an unexpected side effect of weight-loss drugs. Inc.com, meanwhile, framed the developments as two new studies linking GLP-1 drugs such as Ozempic and Wegovy to two unexpected problems.
The coverage across these outlets centers on associations reported in the research rather than established causes, and the available material does not specify how the studies were designed or how large they were. The Washington Post's report focuses specifically on men and hair loss.
Taken together, the reports suggest researchers and clinicians are continuing to track side effects beyond the gastrointestinal issues most commonly associated with GLP-1 drugs.
What to watch next: whether further controlled studies confirm these findings and clarify how common such effects are among GLP-1 users.
